Table 2. Monocarboxylate transporters (MCT) 1–4 in cancer and stromal cells as predictors of disease-specific survival in 335 NSCLC patients (univariate analyses; log-rank test).
| Characteristics | Patients, N (%) | Median survival (months) | 5-year survival (%) | P |
| MCT1 | ||||
| Cancer cells | .021 | |||
| High | 171 (51) | NR | 66 | |
| Low | 149 (44) | 62 | 51 | |
| Missing | 15 (5) | |||
| Stromal cells | .003 | |||
| High | 201 (60) | 71 | 54 | |
| Low | 108 (32) | NR | 70 | |
| Missing | 26 (8) | |||
| MCT2 | ||||
| Cancer cells | .364 | |||
| High | 220 (66) | 127 | 58 | |
| Low | 67 (20) | NR | 64 | |
| Missing | 48 (14) | |||
| Stromal cells | .006 | |||
| High | 83 (25) | NR | 72 | |
| Low | 231 (69) | 127 | 55 | |
| Missing | 21(6) | |||
| MCT3 | ||||
| Cancer cells | .776 | |||
| High | 105 (31) | 190 | 60 | |
| Low | 192 (58) | NR | 59 | |
| Missing | 38 (11) | |||
| Stromal cells | .020 | |||
| High | 277 (83) | 61 | 190 | |
| Low | 32 (9) | 40 | 27 | |
| Missing | 26 (8) | |||
| MCT4 | ||||
| Cancer cells | .027 | |||
| High | 132 (39) | NR | 51 | |
| Low | 178 (53) | 62 | 65 | |
| Missing | 25 (8) | |||
| Stromal cells | .110 | |||
| High | 165 (49) | NR | 62 | |
| Low | 139 (42) | 71 | 53 | |
| Missing | 31 (9) |